JP2021509671A5 - - Google Patents

Info

Publication number
JP2021509671A5
JP2021509671A5 JP2020537006A JP2020537006A JP2021509671A5 JP 2021509671 A5 JP2021509671 A5 JP 2021509671A5 JP 2020537006 A JP2020537006 A JP 2020537006A JP 2020537006 A JP2020537006 A JP 2020537006A JP 2021509671 A5 JP2021509671 A5 JP 2021509671A5
Authority
JP
Japan
Prior art keywords
neonatal
glucose
pharmaceutical composition
oral pharmaceutical
clc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020537006A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021509671A (ja
JP7381469B2 (ja
Filing date
Publication date
Priority claimed from US15/860,966 external-priority patent/US10213491B2/en
Application filed filed Critical
Priority claimed from PCT/US2019/012208 external-priority patent/WO2019136168A1/en
Publication of JP2021509671A publication Critical patent/JP2021509671A/ja
Publication of JP2021509671A5 publication Critical patent/JP2021509671A5/ja
Application granted granted Critical
Publication of JP7381469B2 publication Critical patent/JP7381469B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020537006A 2018-01-03 2019-01-03 新生児抗痙攣薬としてのグルコースオキシダーゼ組成物 Active JP7381469B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/860,966 US10213491B2 (en) 2015-05-19 2018-01-03 Glucose oxidase compositions as a neonate anticonvulsant
US15/860,966 2018-01-03
PCT/US2019/012208 WO2019136168A1 (en) 2018-01-03 2019-01-03 Glucose oxidase compositions as a neonate anticonvulsant

Publications (3)

Publication Number Publication Date
JP2021509671A JP2021509671A (ja) 2021-04-01
JP2021509671A5 true JP2021509671A5 (cg-RX-API-DMAC10.html) 2022-01-14
JP7381469B2 JP7381469B2 (ja) 2023-11-15

Family

ID=67143949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020537006A Active JP7381469B2 (ja) 2018-01-03 2019-01-03 新生児抗痙攣薬としてのグルコースオキシダーゼ組成物

Country Status (5)

Country Link
US (1) US11666640B2 (cg-RX-API-DMAC10.html)
EP (1) EP3735262A4 (cg-RX-API-DMAC10.html)
JP (1) JP7381469B2 (cg-RX-API-DMAC10.html)
CN (1) CN112105378B (cg-RX-API-DMAC10.html)
WO (1) WO2019136168A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111440771A (zh) * 2020-03-17 2020-07-24 中山大学附属第三医院 一种含有clcn2纯合突变的白质脑病患者特异诱导多能干细胞系

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364634A (en) 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
AU6044994A (en) 1993-02-19 1994-09-14 Nippon Shinyaku Co. Ltd. Glycerol derivative, device and pharmaceutical composition
AU7166200A (en) * 1995-12-27 2001-03-08 Genencor International, Inc. Process for the preparation of gluconic acid and gluconic acid produced thereby
US5994316A (en) 1996-02-21 1999-11-30 The Immune Response Corporation Method of preparing polynucleotide-carrier complexes for delivery to cells
JP4024302B2 (ja) 1996-05-17 2007-12-19 クアドラント、 ドラッグ、 デリバリー、 リミテッド 微粒子および創傷治療におけるその用途
US20100029613A1 (en) 2004-11-15 2010-02-04 University Of Rochester Treatment and prevention of epilepsy
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
AU2007347990B2 (en) * 2007-02-28 2011-04-28 Morinaga Milk Industry Co., Ltd. Oral disinfectant and food additive comprising the disinfectant
CN101977625A (zh) 2008-03-20 2011-02-16 克里斯特·坦诺 物质在制备治疗感冒药物中的应用
US8962042B2 (en) 2010-09-28 2015-02-24 Lisa Geng Methods for treating neurological disorders using nutrient compositions
WO2014165566A1 (en) 2013-04-03 2014-10-09 Emory University Hydrophilic particle compositions, processes of production, and uses in dietary management and digestive disorders
KR20160024853A (ko) * 2013-04-30 2016-03-07 메사추세츠 인스티튜트 오브 테크놀로지 당뇨병 치료를 위한 주사형 나노-네트워크 겔
US20170065728A1 (en) 2014-03-03 2017-03-09 The Penn State Research Foundation Self-powered enzyme micropumps
CN104450806B (zh) * 2014-11-27 2018-01-16 江南大学 一种酶法制备葡萄糖酸钠的方法
US9861597B2 (en) 2015-05-19 2018-01-09 Penn State Research Foundation Gluconate-based compositions as a neonate anticonvulsant
US10213491B2 (en) * 2015-05-19 2019-02-26 The Penn State Research Foundation Glucose oxidase compositions as a neonate anticonvulsant
CN106978451B (zh) * 2017-03-29 2020-04-28 华南理工大学 一种固定化葡萄糖氧化酶制备葡萄糖酸钠的方法
CN106929500A (zh) * 2017-04-27 2017-07-07 南京工业大学 葡萄糖氧化酶/过氧化氢酶的交联酶聚体的制备方法及其应用

Similar Documents

Publication Publication Date Title
JP7650929B2 (ja) 成人における焦点てんかんの処置のための合成経皮的カンナビジオール
RU2519660C2 (ru) Режим дозировки селективного агониста рецептора s1p1
JP2022521233A5 (cg-RX-API-DMAC10.html)
EA034940B1 (ru) Лечение пациентов с сахарным диабетом 2 типа
JP2023541007A5 (cg-RX-API-DMAC10.html)
US20240261242A1 (en) Methods of intravenously administering sotalol
CN1505505A (zh) 辅酶q作为活性成分的经粘膜给药的组合物
Chang et al. Status epilepticus
JP2025148449A5 (cg-RX-API-DMAC10.html)
Holzki et al. Death after re‐exposure to propofol in a 3‐year‐old child: a case report
US20210330750A1 (en) Lactate-protected hypoglycemia to treat glycolysis dependent pathological conditions, in particular cancer
JP2023544249A5 (cg-RX-API-DMAC10.html)
JP5117230B2 (ja) 2型糖尿病治療用の併用医薬
US20210177875A1 (en) Methods and compositions for treating childhood or teen obesity
TW202606681A (zh) 紫質症之預防或治療劑
EP4144734A1 (en) Application of heterocyclic compound
Yousif et al. A Double-Blind, Randomized Clinical Trial Comparing Sedation Outcomes of Dexmedetomidine and Ketofol in Pediatric Dental Interventions
JP2022546042A5 (cg-RX-API-DMAC10.html)
Sathaporn et al. A Rare Cause of Refractory Vasodilatory Shock Due to Calcium Channel Blocker Toxicity from Drug-Drug Interaction Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) And Manidipine
Clifford et al. Dimethyl myleran therapy combined with abdominal aortic occlusion
JP2020143037A (ja) 糖尿病合併心不全の治療用医薬組成物
TW202529797A (zh) Glp-1類似物治療代謝疾病的方法及醫藥用途
CN105530929B (zh) 3‑羧基‑n‑乙基‑n,n‑二甲基丙‑1‑铵或其药学上可接受的盐在预防和治疗糖尿病中的用途
CN107970248A (zh) 异甘草酸在制备治疗高血压药物中的用途
TW202612698A (zh) 吞噬血球症候群治療劑及其用途